Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016
- PMID: 31431208
- PMCID: PMC6702794
- DOI: 10.2807/1560-7917.ES.2019.24.33.1800538
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016
Abstract
BackgroundAntibiotic resistance, either intrinsic or acquired, is a major obstacle for treating bacterial infections.AimOur objective was to compare the country-specific species distribution of the four Gram-negative species Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter species and the proportions of selected acquired resistance traits within these species.MethodWe used data reported for 2016 to the European Antimicrobial Resistance Surveillance Network (EARS-Net) by 30 countries in the European Union and European Economic Area.ResultsThe country-specific species distribution varied considerably. While E. coli accounted for 31.9% to 81.0% (median: 69.0%) of all reported isolates, the two most common intrinsically resistant species P. aeruginosa and Acinetobacter spp. combined (PSEACI) accounted for 5.5% to 39.2% of isolates (median: 10.1%). Similarly, large national differences were noted for the percentages of acquired non-susceptibility to third-generation cephalosporins, carbapenems and fluoroquinolones. There was a strong positive rank correlation between the country-specific percentages of PSEACI and the percentages of non-susceptibility to the above antibiotics in all four species (rho > 0.75 for 10 of the 11 pairs of variables tested).ConclusionCountries with the highest proportion of P. aeruginosa and Acinetobacter spp. were also those where the rates of acquired non-susceptibility in all four studied species were highest. The differences are probably related to national differences in antibiotic consumption and infection prevention and control routines.
Keywords: Gram-negative bacilli; antibiotic resistance; antimicrobial resistance; bacterial infections; bloodstream infection.
Conflict of interest statement
Figures


Similar articles
-
Antibiotic Resistance Trends in Carbapenem-Resistant Gram-Negative Pathogens and Eight-Year Surveillance of XDR Bloodstream Infections in a Western Greece Tertiary Hospital.Pathogens. 2024 Dec 23;13(12):1136. doi: 10.3390/pathogens13121136. Pathogens. 2024. PMID: 39770395 Free PMC article.
-
Predicting early appropriate therapy for patients infected by carbapenem-resistant Gram-negative pathogens in intensive care units in Italy.Antimicrob Resist Infect Control. 2024 Aug 26;13(1):91. doi: 10.1186/s13756-024-01452-y. Antimicrob Resist Infect Control. 2024. PMID: 39183351 Free PMC article.
-
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.Int J Antimicrob Agents. 2005 Dec;26(6):463-72. doi: 10.1016/j.ijantimicag.2005.08.016. Epub 2005 Nov 8. Int J Antimicrob Agents. 2005. PMID: 16280243 Free PMC article.
-
Clinical and economic impact of common multidrug-resistant gram-negative bacilli.Antimicrob Agents Chemother. 2008 Mar;52(3):813-21. doi: 10.1128/AAC.01169-07. Epub 2007 Dec 10. Antimicrob Agents Chemother. 2008. PMID: 18070961 Free PMC article. Review. No abstract available.
-
Treatment Options for Carbapenem- Resistant Gram-Negative Infections.Dtsch Arztebl Int. 2018 May 21;115(20-21):345-352. doi: 10.3238/arztebl.2018.0345. Dtsch Arztebl Int. 2018. PMID: 29914612 Free PMC article. Review.
Cited by
-
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review.Antibiotics (Basel). 2022 Apr 26;11(5):579. doi: 10.3390/antibiotics11050579. Antibiotics (Basel). 2022. PMID: 35625223 Free PMC article. Review.
-
A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates.mSphere. 2021 Dec 22;6(6):e0086821. doi: 10.1128/msphere.00868-21. Epub 2021 Dec 22. mSphere. 2021. PMID: 34935444 Free PMC article.
-
Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models.BMC Infect Dis. 2023 Apr 18;23(1):247. doi: 10.1186/s12879-023-08182-3. BMC Infect Dis. 2023. PMID: 37072711 Free PMC article.
-
Effect on Antimicrobial Resistance of a Policy Restricting Over-the-Counter Antimicrobial Sales in a Large Metropolitan Area, São Paulo, Brazil.Emerg Infect Dis. 2022 Jan;28(1):180-187. doi: 10.3201/eid2801.201928. Emerg Infect Dis. 2022. PMID: 34932455 Free PMC article.
-
A retrospective study on Escherichia coli bacteremia in immunocompromised patients: Microbiological features, clinical characteristics, and risk factors for shock and death.J Clin Lab Anal. 2020 Aug;34(8):e23319. doi: 10.1002/jcla.23319. Epub 2020 Apr 8. J Clin Lab Anal. 2020. PMID: 32267010 Free PMC article.
References
-
- European Centre for Disease Prevention and Control (ECDC). Surveillance of antimicrobial resistance in Europe 2016. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/AMR-surveillance-Eur...
-
- European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012. Stockholm: ECDC; 2013. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publicat... - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous